Quercetin analogs with high fetal hemoglobin-inducing activity

• Published in: Medicinal chemistry research 2019-10, Vol.28 (10), p.1755-1765
• Main Authors: Pabuprapap, Wachirachai, Wassanatip, Yanisa, Khetkam, Pichit, Chaichompoo, Waraluck, Kunkaewom, Sukanya, Senabud, Pongpan, Hata, Janejira, Chokchaisiri, Ratchanaporn, Svasti, Saovaros, Suksamrarn, Apichart
• Format: Article
• Language: English
• Subjects: Analogs; Biochemistry; Biomedical and Life Sciences; Biomedicine; Cell Biology; Chains; Chemical modification; Cisplatin; Cytotoxicity; Developing countries; Fetuses; Flavonoids; Gene expression; Hemin; Hemoglobin; Herbal medicine; Hydroxyl groups; LDCs; Medicinal plants; Organic chemistry; Original Research; Pharmacology/Toxicology; Quercetin; Thalassemia
• ISSN: 1054-2523; 1554-8120
• DOI: 10.1007/s00044-019-02412-7

β -Thalassemia is the major health problems in developing countries, when affected patients and healthy carriers are numerous, resulting a total absence or severe decrease in the production of β -globin chains. The use of chemical agents for increasing the production of fetal hemoglobin (HbF) by reactivating γ -globin gene to balance excess α -globin chains is an alternative therapeutic approach. Therefore, the search for molecules exhibiting the property of inducing γ -globin gene expression is of great interest. In this report, we discovered that quercetin ( 1 ), the major flavonoid isolated from the heartwoods of the medicinal plant Anaxagorea luzonensis promoted the expression of γ -globin gene. Chemical modification of 1 to fourteen methyl ether analogs ( 2 − 15 ) was conducted. The structures of these compounds were established on the basis of their spectroscopic data and by comparison with those of the reported values. The parent flavonoid and its chemically modified analogs were investigated for their γ -globin gene induction for the first time. The parent compound 1 exhibited less induced γ -globin gene expression than cisplatin and hemin, the positive controls. 3,4′-Di- O -methylquercetin ( 7 ), the modified analog, significantly enhanced γ -globin gene expression with 2.6-fold change at 8 μM, which was slightly higher than cisplatin and hemin. Moreover, compounds 1 and 7 displayed less cytotoxic activity against K562::Δ G γ A γ EGFP cells than cisplatin. Structure-activity relationship (SAR) study revealed that the methoxyl groups at the 3- and 4ʹ-positions and the free hydroxyl group at the 7-position are required for strong HbF-inducing activity.